Zevra Therapeutics, Inc. (ZVRA) Tops Q1 EPS by 7c

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) reported Q1 EPS of ($0.40), $0.07 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $3.42 million versus the consensus estimate of $3.76 million.

For earnings history and earnings-related data on Zevra Therapeutics, Inc. (ZVRA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Reading (RDI) Tops Q2 EPS by 4c